Mereo BioPharma Group plc ADR

Historical 13F Holders

Symbol
MREO
CUSIP
589492107
All holders as of
Q2 2026
Type
Equity
Class
SPON ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 589492107 since 12/18/2024, largest first.

Filer % of Class Filed
683 Capital Management, LLC 13G
8.2% 1/6/2026
Event 12/29/2025
Adage Capital Partners GP, L.L.C. 13G/A
5.6% 2/12/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Mangrove Partners IM, LLC 13G/A
4.9% 11/14/2025
Event 9/30/2025
Rock Springs Capital Management LP 13G/A
4.2% 5/15/2025
Event 3/31/2025
Adage Capital Management, L.P. 13G/A
1.1% 5/12/2025
Event 3/31/2025
EcoR1 Capital, LLC 13G/A
0.6% 8/14/2026
Event 6/30/2026
Frazier Life Sciences Public Fund, L.P. 13G/A
0% 2/13/2026
Event 12/31/2025
Janus Henderson Group PLC 13G/A 0% 2/17/2026
Event 12/31/2025
Northpond Ventures, LP 13G/A
0% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 1.99 k $800.00
2026 Q2 65 56.6 M $18.0 M
2026 Q1 69 75.4 M $24.9 M
2025 Q4 80 62.0 M $25.8 M
2025 Q3 95 100 M $205 M
2025 Q2 101 98.7 M $268 M
2025 Q1 102 111 M $250 M
2024 Q4 99 115 M $403 M
2024 Q3 85 106 M $435 M
2024 Q2 86 101 M $363 M
2024 Q1 90 86.8 M $287 M
2023 Q4 73 80.7 M $186 M
2023 Q3 60 70.5 M $90.4 M
2023 Q2 58 64.7 M $84.5 M
2023 Q1 62 61.1 M $43.2 M
2022 Q4 64 61.6 M $46.2 M
2022 Q3 68 68.0 M $58.5 M
2022 Q2 72 74.2 M $82.7 M
2022 Q1 64 89.8 M $99.9 M
2021 Q4 80 92.1 M $146 M
2021 Q3 68 88.4 M $212 M
2021 Q2 80 92.3 M $290 M
2021 Q1 76 97.4 M $325 M
2020 Q4 50 59.9 M $211 M
2020 Q3 29 15.5 M $38.1 M
2020 Q2 25 7.28 M $22.3 M
2020 Q1 15 3.28 M $3.42 M
2019 Q4 15 1.24 M $4.08 M
2019 Q3 17 1.78 M $5.21 M
2019 Q2 19 1.80 M $4.39 M